Precision Tissue Microablation Platform for Personalized Treatment

A next-generation tissue microablation system that integrates artificial intelligence, real-time feedback, and advanced laser technology to provide customized treatment protocols for skin and tissue conditions.

The original patent's limitations in terms of treatment pattern customization, real-time feedback, and optimal treatment outcomes are addressed by this new inventive concept, which leverages advancements in AI, imaging modalities, and laser technology to provide a more effective and personalized treatment solution.

The precision tissue microablation platform consists of a laser unit, a laser emitting device, and an AI-powered control system. The control system analyzes patient-specific skin and tissue characteristics to generate a customized treatment protocol, which is then executed by the laser emitting device to create a three-dimensional pattern of microchannels with varying depths and diameters. The system features a real-time feedback mechanism utilizing optical coherence tomography or other imaging modalities to monitor and adjust microchannel creation during treatment. Additionally, a novel laser beam splitter creates a fractional pattern of treatment radiation with dynamically adjustable parameters for optimal treatment outcomes.

The new claims introduce a paradigm shift in tissue microablation by incorporating AI-driven customization, real-time feedback, and advanced laser technology, which are not present in the original patent. The inventive concept's novelty lies in its ability to provide personalized treatment protocols, optimize treatment outcomes, and enable clinicians to visualize and simulate treatments prior to actual treatment.

Alternative embodiments of the inventive concept could include the use of different imaging modalities, such as ultrasound or MRI, to provide real-time feedback. Additionally, the system could be adapted for use in various medical specialties, such as dermatology, plastic surgery, or ophthalmology.

The precision tissue microablation platform has significant commercial potential in the medical aesthetics and healthcare industries, particularly in the treatment of skin and tissue conditions such as acne, rosacea, and skin cancer. The system's ability to provide personalized treatment protocols and optimize treatment outcomes could lead to increased adoption and market share in these industries.